Osteonecrosis of the Femoral Head: an Updated Review of ARCO on Pathogenesis, Staging and Treatment.

Abstract

Non-traumatic osteonecrosis of the femoral head (ONFH) usually affects adults younger than 50 years and frequently leads to femoral head collapse and subsequent arthritis of the hip. It is becoming more prevalent along with increasing use of corticosteroids for the adjuvant therapy of leukemia and other myelogenous diseases as well as management of organ transplantation. This review updated knowledge on the pathogenesis, classification criteria, staging system, and treatment of ONFH.

• Authors: Jeremy T Hines, Woo Lam Jo, Quanjun Cui, Michael A Mont, Kyung Hoi Koo, Edward Y Cheng, Stuart B Goodman, Yong Chan Ha, Phillippe Hernigou, Lynne C Jones, Shin Yoon Kim, Takashi Sakai, Nobuhiko Sugano, Takuaki Yamamoto, Mel S Lee, Dewei Zhao, Wolf Drescher, Tae Young Kim, Young Kyun Lee, Byung Ho Yoon, Seung Hoon Baek, Wataru Ando, Hong Seok Kim, Jung Wee Park
• Journal: Journal of Korean medical science (J Korean Med Sci) Vol. 36 Issue 24 Pg. e177 (Jun 21 2021) ISSN: 1598-6357 [Electronic] Korea (South)
• PMID: 34155839 (Publication Type: Journal Article, Review)
• Copyright: © 2021 The Korean Academy of Medical Sciences.

Chemical References

• Glucocorticoids
• Prednisolone

Topics

• Femur Head (pathology)
• Femur Head Necrosis (classification, pathology)
• Glucocorticoids (adverse effects)
• Hip (pathology)
• Humans
• Osteonecrosis (pathology, therapy)
• Prednisolone (adverse effects)